Zobrazeno 1 - 10
of 588
pro vyhledávání: '"Osoba, D."'
Publikováno v:
Journal of Clinical Oncology; 12/10/2023, Vol. 41 Issue 35, p5345-5350, 6p
Autor:
Maringwa, J. *, Quinten, C., King, M., Ringash, J., Osoba, D., Coens, C., Martinelli, F., Reeve, B.B., Gotay, C., Greimel, E., Flechtner, H., Cleeland, C.S., Schmucker-Von Koch, J., Weis, J., Van Den Bent, M.J., Stupp, R., Taphoorn, M.J., Bottomley, A.
Publikováno v:
In Annals of Oncology September 2011 22(9):2107-2112
Autor:
Pater, J.1, Osoba, D.2, Zee, B.1, Lofters, W.3, Gore, M.4, Dempsey, E.4, Palmer, M.1, Chin, C.4
Publikováno v:
Quality of Life Research. May1998, Vol. 7 Issue 3, p273-278. 6p.
Autor:
Quinten, C., Martinelli, F., Coens, C., Sprangers, M.A.G., Ringash, J., Gotay, C., Bjordal, K., Greimel, E., Reeve, B.B., Maringwa, J., Ediebah, D.E., Zikos, E., King, M.T., Osoba, D., Taphoorn, M.J., Flechtner, H., Koch, J., Weis, J., Bottomley, A.
Publikováno v:
Cancer, 120(2), 302-311. John Wiley and Sons Inc.
Quinten, C, Martinelli, F, Coens, C, Sprangers, M A G, Ringash, J, Gotay, C, Bjordal, K, Greimel, E, Reeve, B B, Maringwa, J, Ediebah, D E, Zikos, E, King, M T, Osoba, D, Taphoorn, M J, Flechtner, H, Koch, J, Weis, J & Bottomley, A 2014, ' Global Analysis of Multitrial Data Investigating Quality of Life and Symptoms as Prognostic Factors for Survival in Different Tumor Sites ', Cancer, vol. 120, no. 2, pp. 302-311 . https://doi.org/10.1002/cncr.28382
Quinten, C, Martinelli, F, Coens, C, Sprangers, M A G, Ringash, J, Gotay, C, Bjordal, K, Greimel, E, Reeve, B B, Maringwa, J, Ediebah, D E, Zikos, E, King, M T, Osoba, D, Taphoorn, M J, Flechtner, H, Koch, J, Weis, J & Bottomley, A 2014, ' Global Analysis of Multitrial Data Investigating Quality of Life and Symptoms as Prognostic Factors for Survival in Different Tumor Sites ', Cancer, vol. 120, no. 2, pp. 302-311 . https://doi.org/10.1002/cncr.28382
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::efb067ae033082d9e4ec2d76cea035eb
https://research.vumc.nl/en/publications/218dc8f5-33bb-4d4b-b6f2-bf39ce259f5d
https://research.vumc.nl/en/publications/218dc8f5-33bb-4d4b-b6f2-bf39ce259f5d
OBJECTIVE: To compare Cohen's guidelines for small (0.2), medium (0.5), and large (0.8) effect sizes with empirical estimates for a cancer-specific health-related quality-of-life questionnaire (HRQOL), the Functional Assessment of Cancer Therapy - Ge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______363::fb8b67fafb4f112d146667e17b2ee2fa
https://hdl.handle.net/10453/17035
https://hdl.handle.net/10453/17035
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Quality of life research, 6(2), 103-108. Springer Netherlands
A revision of the Quality of Life Questionnaire (QLQ-C30) of the European Organization for Research and Treatment of Cancer (EORTC) was undertaken to improve low internal consistency estimates (Cronbach's alpha) and content validity for the role func
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::d3e22b964fe54dcf0854b0e42e7f715c
https://pure.amc.nl/en/publications/modification-of-the-eortc-qlqc30-version-20-based-on-content-validity-and-reliability-testing-in-large-samples-of-patients-with-cancer-the-study-group-on-quality-of-life-of-the-eortc-and-the-symptom-control-and-quality-of-life-committees-of-the-nci-of-canada-clinical-trials-group(ecaee62a-52a4-47fa-8333-6975a9eaa127).html
https://pure.amc.nl/en/publications/modification-of-the-eortc-qlqc30-version-20-based-on-content-validity-and-reliability-testing-in-large-samples-of-patients-with-cancer-the-study-group-on-quality-of-life-of-the-eortc-and-the-symptom-control-and-quality-of-life-committees-of-the-nci-of-canada-clinical-trials-group(ecaee62a-52a4-47fa-8333-6975a9eaa127).html
Publikováno v:
Europe PubMed Central
Scopus-Elsevier
Scopus-Elsevier
Since 1989, the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) has been successful in implementing and completing health-related quality-of-life (HQL) assessments as part of phase III clinical trials. Compliance rates for comple
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.